TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
CellMark AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,417,367
|
3,448,560
|
3,865,691 |
| Financial expenses |
31,076
|
34,525
|
17,760 |
| Earnings before taxes |
28,989
|
43,444
|
83,461 |
| EBITDA |
61,623
|
75,259
|
104,512 |
| Total assets |
1,044,501
|
881,114
|
1,119,613 |
| Current assets |
961,677
|
815,957
|
1,059,265 |
| Current liabilities |
840,149
|
676,136
|
889,461 |
| Equity capital |
185,492
|
191,667
|
215,037 |
| - share capital |
785
|
812
|
810 |
| Employees (average) |
963
|
1,061
|
1,031 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
17.8%
|
21.8%
|
19.2% |
| Turnover per employee |
3,549
|
3,250
|
3,749 |
| Profit as a percentage of turnover |
0.8%
|
1.3%
|
2.2% |
| Return on assets (ROA) |
5.8%
|
8.8%
|
9.0% |
| Current ratio |
114.5%
|
120.7%
|
119.1% |
| Return on equity (ROE) |
15.6%
|
22.7%
|
38.8% |
| Change turnover |
86,045
|
-428,384
|
1,037,871 |
| Change turnover % |
3%
|
-11%
|
37% |
| Chg. No. of employees |
-98
|
30
|
123 |
| Chg. No. of employees % |
-9%
|
3%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.